EBR Says US Federal Agency Proposes to Approve Add-On Payment for Heart Failure Treatment Device

MT Newswires Live

2025/04/15

EBR Systems (ASX:EBR) said that the US Centers for Medicare & Medicaid Services has proposed the approval of a new technology add-on payment for the company's WiSE cardiac resynchronization therapy system for the treatment of heart failure, according to a Tuesday filing with the Australian bourse.

If approved, the maximum add-on payment will be 65% of the device cost in addition to standard Medicare payments and will be effective for three years starting Oct. 1, the filing said.

The company plans to seek similar support for outpatient use, the filing added.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2527173955"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2527173955\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2527173955?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-15 08:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2527173955","market":"sg","top_or_hot":-1,"title":"EBR Says US Federal Agency Proposes to Approve Add-On Payment for Heart Failure Treatment Device","media":"MT Newswires Live","content":"<html><body><p> EBR Systems (ASX:EBR) said that the US Centers for Medicare &amp; Medicaid Services has proposed the approval of a new technology add-on payment for the company's WiSE cardiac resynchronization therapy system for the treatment of heart failure, according to a Tuesday filing with the Australian bourse.</p><p>If approved, the maximum add-on payment will be 65% of the device cost in addition to standard Medicare payments and will be effective for three years starting Oct. 1, the filing said.</p><p>The company plans to seek similar support for outpatient use, the filing added.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EBR Says US Federal Agency Proposes to Approve Add-On Payment for Heart Failure Treatment Device</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEBR Says US Federal Agency Proposes to Approve Add-On Payment for Heart Failure Treatment Device\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-04-15 08:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> EBR Systems (ASX:EBR) said that the US Centers for Medicare &amp; Medicaid Services has proposed the approval of a new technology add-on payment for the company's WiSE cardiac resynchronization therapy system for the treatment of heart failure, according to a Tuesday filing with the Australian bourse.</p><p>If approved, the maximum add-on payment will be 65% of the device cost in addition to standard Medicare payments and will be effective for three years starting Oct. 1, the filing said.</p><p>The company plans to seek similar support for outpatient use, the filing added.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EBR.AU","symbol_name":"EBR SYSTEMS INC-CDI","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2527173955","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2527173955","pubTimestamp":1744676023,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"EBR Systems  said that the US Centers for Medicare & Medicaid Services has proposed the approval of a new technology add-on payment for the company's WiSE cardiac resynchronization therapy system for the treatment of heart failure, according to a Tuesday filing with the Australian bourse.If approved, the maximum add-on payment will be 65% of the device cost in addition to standard Medicare payments and will be effective for three years starting Oct. 1, the filing said.The company plans to seek similar support for outpatient use, the filing added.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EBR.AU":"EBR SYSTEMS INC-CDI","IE00B1B80R65.USD":"柏瑞拉丁美洲股票A","BK4081":"电力公用事业","BK7007":"医疗保健设备"},"translate_title":"EBR称美国联邦机构提议批准心力衰竭治疗设备的附加付款","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EBR":1,"US12M.BOND":1,"US3Y.BOND":1,"EBR.AU":0.9,"US7Y.BOND":1,"US6M.BOND":1,"US2Y.BOND":1,"US5Y.BOND":1,"US10Y.BOND":1,"US30Y.BOND":1},"content_text":"EBR Systems (ASX:EBR) said that the US Centers for Medicare & Medicaid Services has proposed the approval of a new technology add-on payment for the company's WiSE cardiac resynchronization therapy system for the treatment of heart failure, according to a Tuesday filing with the Australian bourse.If approved, the maximum add-on payment will be 65% of the device cost in addition to standard Medicare payments and will be effective for three years starting Oct. 1, the filing said.The company plans to seek similar support for outpatient use, the filing added.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}